logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Brentuximab-vedotinNeutropenia and infusion reaction: 2 case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2021年 / 1867卷 / 1期
关键词:
D O I:
10.1007/s40278-021-00155-4
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:95 / 95
相关论文
共 50 条
  • [31] Brentuximab vedotinAlopecia: case report
    Reactions Weekly, 2015, 1544 (1) : 57 - 57
  • [32] Brentuximab vedotinPolyneuropathy: case report
    Reactions Weekly, 2018, 1732 (1) : 98 - 98
  • [33] Brentuximab vedotinEythroderma: case report
    Reactions Weekly, 2024, 2022 (1) : 71 - 71
  • [34] Brentuximab vedotinNeuropathy : case report
    Reactions Weekly, 2024, 2018 (1) : 97 - 97
  • [35] AntineoplasticsLack of efficacy and infusion reaction: case report
    Reactions Weekly, 2022, 1890 (1) : 44 - 44
  • [36] PembrolizumabHypotension as a symptom to infusion reaction: case report
    Reactions Weekly, 2020, 1804 (1) : 236 - 236
  • [37] Brentuximab vedotinAnaphylaxis: case report
    Reactions Weekly, 2019, 1778 (1) : 98 - 98
  • [38] Azathioprine/infliximabHypertransaminasaemia and infusion reaction: case report
    Reactions Weekly, 2011, 1350 (1) : 13 - 13
  • [39] TrastuzumabSevere delayed infusion reaction: case report
    Reactions Weekly, 2013, 1465 (1) : 36 - 36
  • [40] DocetaxelBullous reaction at infusion site: case report
    Reactions Weekly, 2014, 1484 (1) : 16 - 16
← 12345 →